financetom
Business
financetom
/
Business
/
Aurinia Pharmaceuticals Q3 Earnings, Total Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Aurinia Pharmaceuticals Q3 Earnings, Total Revenue Rise
Nov 4, 2025 6:35 AM

09:02 AM EST, 11/04/2025 (MT Newswires) -- Aurinia Pharmaceuticals ( AUPH ) reported Q3 earnings Tuesday of $0.23 per diluted share, up from $0.10 a year earlier.

Analysts polled by FactSet expected $0.16.

Total revenue for the quarter ended Sept. 30 was $73.5 million, up from $67.8 million a year earlier.

Analysts polled by FactSet expected $67.7 million.

The company said it now expects 2025 total revenue of $275 million to $280 million, up from its earlier guidance of between $260 million and $270 million. Analysts polled by FactSet expect $270.5 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved